Short Read Sequencing Market Growth Outlook Through 2024-2033

Overview and Scope
Short-read sequencing, or next-generation sequencing (NGS), is a high-throughput DNA sequencing method that generates short fragments or reads of DNA sequences. It revolutionized genomics by enabling the rapid and cost-effective analysis of entire genomes and transcriptomes.

Sizing and Forecast
The short read sequencing market size has grown rapidly in recent years. It will grow from $5.74 billion in 2023 to $6.82 billion in 2024 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to genomic research initiatives, increased prevalence of genetic disorders, pharmaceutical and biotech research, diagnostic applications, declining sequencing costs..

The short read sequencing market size is expected to see rapid growth in the next few years. It will grow to $12.97 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to precision medicine advancements, rapid growth in personalized genomics, expanding applications in agriculture, surge in microbiome research, rising demand in emerging markets.. Major trends in the forecast period include automation and high-throughput, cloud-based solutions, integration of ai and machine learning, portable sequencing technologies, long-read sequencing synergy..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Segmentation & Regional Insights
The short read sequencing market covered in this report is segmented –

1) By Product: Instruments, Consumables, Services.
2) By Technology: Next-Generation Sequencing, Sanger Sequencing.
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.
4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics and Forensics, HLA Typing/ Immune System Monitoring.
5) By End Users: Academic Research, Hospitals and Clinics, Clinical Research, Pharmaceutical and Biotechnology Companies.

North America was the largest region in the Short Read Sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp

Major Driver Impacting Market Growth
The rising prevalence of genetic diseases is expected to propel the growth of the short-read sequencing market going forward. Genetic diseases are conditions caused by abnormalities or mutations in an individual’s DNA or genes, leading to physical, developmental, or biochemical abnormalities that can impact their health and well-being. Short-read sequencing is used in genetic diseases to analyze the genome and identify disease-associated variants comprehensively. For instance, in June 2022, according to a report published by RARE-X, an Australia-based patient support platform, there were a total of 10,867 rare diseases, encompassing both genetic and non-genetic conditions. Therefore, the rising prevalence of genetic diseases is driving the growth of the short-read sequencing market.

Key Industry Players
Major companies operating in the short read sequencing market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd, MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, GnuBIO Inc., Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG, Halcyon Molecular Inc.

The short read sequencing market report table of contents includes:

1. Executive Summary
2. Short-Read Sequencing Market Characteristics
3. Short-Read Sequencing Market Trends And Strategies
4. Short-Read Sequencing Market – Macro Economic Scenario
5. Global Short-Read Sequencing Market Size and Growth
.
.
.
32. Global Short-Read Sequencing Market Competitive Benchmarking
33. Global Short-Read Sequencing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Short-Read Sequencing Market
35. Short-Read Sequencing Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model